Fortaleza Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Fortaleza Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$206K	Sell	3,435 -1,545	-31%	-$80K	1.67%	6
2018 Q1	$228K	Buy	4,980 +2,270	+84%	+$94.7K	1.39%	20
2017 Q4	$108K	Hold	2,710	–	–	0.68%	75
2017 Q3	$108K	Sell	2,710 -2,415	-47%	-$105K	0.2%	136
2017 Q2	$221K	Hold	5,125	–	–	0.42%	73
2017 Q1	$160K	Buy	+5,125	New	+$137K	0.32%	99

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fortaleza Asset Management's SUPN Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Supernus Pharmaceuticals (SUPN) stake by 31% in Q2 2018, selling an estimated $80K and leaving 3,435 shares worth $206K. The position accounts for 1.67% of the portfolio, ranked #6.

Fortaleza Asset Management first reported a position in SUPN in Q1 2017 and has held it in 6 quarters since. The position peaked at $228K in Q1 2018. 320 funds tracked by Wall St. Rank hold SUPN as of Q2 2018.

Fortaleza Asset Management held 3,435 shares of Supernus Pharmaceuticals worth $206K as of Q2 2018.
Fortaleza Asset Management sold 1,545 Supernus Pharmaceuticals shares in Q2 2018, an estimated $80K.
Supernus Pharmaceuticals made up 1.67% of Fortaleza Asset Management's portfolio in Q2 2018, its #6 holding.
Fortaleza Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2017 and has held it in 6 quarters since.
Fortaleza Asset Management's Supernus Pharmaceuticals position peaked at $228K in Q1 2018.
320 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.